IMPORTANCE OF AVASTHIKI CHIKITSA IN PAKSHAGHATA AND ITS COMPLICATIONS: A CLINICAL CASE REPORT
Purpose: Life style disorders demand a strict regimen throughout one’s life among which Hypertension and Diabetes Mellitus are common. Hence the treatment aims an effective control along with Life style modification. The negligence towards the prescribed life style regimen would lead to many complications among which stroke are most prominent and the prevalence in India is 29%. Though the patient is under strict Anti hypertensive medications still one day he/she will land up in stroke hampering his rest of precious life. Aim: With this understanding a successful case report is presented to highlight the importance of Avasthiki Chikitsa with life style modification in controlling Hypertension and treating Pakshaghata from the root level. Materials and Methods: A 74 years old female patient, known case of HTN and DM was brought on a stretcher to the Panchakarma OPD of KLEU Ayurveda Hospital and Research Centre with the complain of loss of strength in left upper and lower limb associated with inability to speak since 9 days. Her MRI suggested Left Hemiplegia with B/L cerebellar hemorrhagic infract in occipital lobe. Initially treatment commenced with Shiromarmaghata Chikitsa with Shamanoushadhi along with modern medication which the patient had been advised. Later on when the patient started to improve in her blood parameters allied science medications were tapered and gradually stopped excluding her routine medication. After the clearance of Avarana Panchakarma therapies were administered sequentially at various stage with a meticulous diet and exercise. Results: After 22 days of treatment Diabetes and Hypertension were under control, patient was able to walk with minimal support and speech also improved. Conclusion:A well planned diet along with Ayurvedic therapies based on the awastha provides encouraging results in treating HTN, DM and Pakshaghata.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.